Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 386,197Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Adcock Ingram

02 1Amgen Inc

03 12Celltrion

04 2CinnaGen Co

05 2Dr Reddy's Laboratories (Pty) Ltd

06 18F. Hoffmann-La Roche

07 4Genentech

08 8Pfizer Consumer Healthcare

09 3Pfizer Inc

10 11Sandoz B2B

11 2iQone Healthcare Switzerland SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB-ARRX

Brand Name : RIABNI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761140

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB-ABBS

Brand Name : TRUXIMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761088

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB-ABBS

Brand Name : TRUXIMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/50ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761088

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximab

Brand Name : Zytux

Dosage Form : Injectable

Dosage Strength : 100MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximab

Brand Name : Zytux

Dosage Form : Injectable

Dosage Strength : 500MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

rituximab

Brand Name : Mabthera

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

rituximab

Brand Name : Mabthera

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

rituximab

Brand Name : MabThera

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 1400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximab

Brand Name : Mabthera

Dosage Form : Rituximab 100Mg 10Ml 2 Units Parenteral Use

Dosage Strength : 2 VIALS EV 100 mg 10 ml 10 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximab

Brand Name : Mabthera

Dosage Form : Rituximab 500Mg 50Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 500 mg 50 ml 10 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximab

Brand Name : Mabthera

Dosage Form : Rituximab 140011,7Mg Ml 1 Units Parenteral Use

Dosage Strength : 1 vial SC 1,400 mg/11.7 ml 15 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximabum

Brand Name : MabThera

Dosage Form : Inf Konz

Dosage Strength : 100mg/10ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximabum

Brand Name : MabThera

Dosage Form : Inf Konz

Dosage Strength : 500mg/50ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rituximabum

Brand Name : MabThera subcutane

Dosage Form : Inj L?s

Dosage Strength : 1400mg/11.7ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB

Brand Name : RITUXAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 100MG/10ML (10MG/ML)

Packaging :

Approval Date :

Application Number : 103705

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB

Brand Name : RITUXAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 500MG/50ML (10MG/ML)

Packaging :

Approval Date :

Application Number : 103705

Regulatory Info :

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)

Brand Name : RITUXAN HYCELA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1400MG and 23400UNITS/11.7ML

Packaging :

Approval Date :

Application Number : 761064

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)

Brand Name : RITUXAN HYCELA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1600MG and 26800UNITS/13.4ML

Packaging :

Approval Date :

Application Number : 761064

Regulatory Info :

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB-PVVR

Brand Name : RUXIENCE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761103

Regulatory Info :

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RITUXIMAB-PVVR

Brand Name : RUXIENCE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/50ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761103

Regulatory Info :

Registration Country : USA

blank